Larvol Delta - Atsena-Therapeutics-Granted-US-FDA-Fast-Track-Designation-for-ATSN201-Gene-Therapy-to-Treat-Xlinked-Retinoschisis

ATSN-201 - Atsena Therap

https://www.globenewswire.com/news-release/2025/03/12/3041253/0/en/Atsena-Therapeutics-Granted-U-S-FDA-Fast-Track-Designation-for-ATSN-201-Gene-Therapy-to-Treat-X-linked-Retinoschisis.html

Mar 12, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next